SEO URLwww.firestrike.ai/deals/lumabridge-avance-clinical-acquisition-2026
acquisitionAnnounced · Jan 7, 2026Clinical Research OrganizationSource · CredibleArticle · Factual
Avance Clinical acquires LumaBridge
David Najork · Founding Software Engineer
Published · Updated · 1 min read
Deal value
—
Target
LumaBridge
San Antonio, Texas
Acquirer
Avance Clinical
Full Acquisition
Status
Announced
Avance Clinical agreed to acquire LumaBridge. Reported deal value: Undisclosed. Status: Announced. Sector: Clinical Research Organization. Target headquarters context: San Antonio, Texas, United States.
This page summarizes publicly available information about the transaction as of 2026-01-07. Figures and status may change as filings and press coverage update.
Avance Clinical , a global contract research organization focused on accelerating clinical development for biotech sponsors, today announced the acquisition of LumaBridge , a specialized U.S. - based clinical CRO with deep expertise in oncology trials
Deal timeline
Announced
Jan 7, 2026 · biospace.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in Clinical Research Organization. Figures and status may change as sources update.
Sources: biospace.com · Primary article · FireStrike proprietary index